On May 13, 2014, ALJ Theodore R. Essex issued Order No. 48 in Certain Omega-3 Extracts from Marine or Aquatic Biomass and Products Containing the Same (Inv. No. 337-TA-877).
According to the Order, ALJ Essex granted Complainants Neptune Technologies & Bioressources Inc. and Ascati Pharma Inc. and Respondents Enzymotec Ltd. and Enzymotec USA, Inc.’s (collectively, “Enzymotec”) joint motion to terminate the investigation as to Enzymotec on the basis of a settlement and license agreement reached between the parties.